HEADER TRANSFERASE 28-APR-17 5NTT TITLE CRYSTAL STRUCTURE OF HUMAN MPS1 (TTK) C604Y MUTANT IN COMPLEX WITH TITLE 2 NMS-P715 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE,PYT; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTK, MPS1, MPS1L1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MPS1, TTK, KINASE, INHIBITOR, NMS-P715, MUTANT, C604Y, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.HIRUMA,R.P.JOOSTEN,A.PERRAKIS REVDAT 4 17-JAN-24 5NTT 1 REMARK REVDAT 3 13-SEP-17 5NTT 1 JRNL REVDAT 2 02-AUG-17 5NTT 1 REVDAT 1 26-JUL-17 5NTT 0 JRNL AUTH Y.HIRUMA,A.KOCH,N.HAZRATY,F.TSAKOU,R.H.MEDEMA,R.P.JOOSTEN, JRNL AUTH 2 A.PERRAKIS JRNL TITL UNDERSTANDING INHIBITOR RESISTANCE IN MPS1 KINASE THROUGH JRNL TITL 2 NOVEL BIOPHYSICAL ASSAYS AND STRUCTURES. JRNL REF J. BIOL. CHEM. V. 292 14496 2017 JRNL REFN ESSN 1083-351X JRNL PMID 28726638 JRNL DOI 10.1074/JBC.M117.783555 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 11748 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 577 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2270 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 57 REMARK 3 SOLVENT ATOMS : 32 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 73.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.96000 REMARK 3 B22 (A**2) : -2.27000 REMARK 3 B33 (A**2) : 1.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.567 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.288 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.252 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 29.224 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5NTT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-APR-17. REMARK 100 THE DEPOSITION ID IS D_1200004717. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5-9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07227 REMARK 200 MONOCHROMATOR : SI (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.31 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12326 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 41.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.15000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 1.43700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.17, PHASER REMARK 200 STARTING MODEL: 5MRB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10.5% (W/V) PEG 350 MME, 10 MM MGCL2, REMARK 280 AND 100 MM TRIS/HCL, PH 7.4, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.33600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.00500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 58.06300 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.33600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 56.00500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 58.06300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.33600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 56.00500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 58.06300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.33600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 56.00500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.06300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 647 54.47 -164.26 REMARK 500 THR A 676 -139.63 73.78 REMARK 500 TPO A 686 137.42 -34.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SVE A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 803 DBREF 5NTT A 519 797 UNP P33981 TTK_HUMAN 519 797 SEQADV 5NTT GLU A 511 UNP P33981 EXPRESSION TAG SEQADV 5NTT ASN A 512 UNP P33981 EXPRESSION TAG SEQADV 5NTT LEU A 513 UNP P33981 EXPRESSION TAG SEQADV 5NTT TYR A 514 UNP P33981 EXPRESSION TAG SEQADV 5NTT PHE A 515 UNP P33981 EXPRESSION TAG SEQADV 5NTT GLN A 516 UNP P33981 EXPRESSION TAG SEQADV 5NTT SER A 517 UNP P33981 EXPRESSION TAG SEQADV 5NTT MET A 518 UNP P33981 EXPRESSION TAG SEQADV 5NTT TYR A 604 UNP P33981 CYS 604 ENGINEERED MUTATION SEQRES 1 A 287 GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS GLY ARG SEQRES 2 A 287 ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY GLY SER SEQRES 3 A 287 SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS GLN ILE SEQRES 4 A 287 TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA ASP ASN SEQRES 5 A 287 GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA TYR LEU SEQRES 6 A 287 ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE ARG LEU SEQRES 7 A 287 TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR MET VAL SEQRES 8 A 287 MET GLU TYR GLY ASN ILE ASP LEU ASN SER TRP LEU LYS SEQRES 9 A 287 LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SER TYR SEQRES 10 A 287 TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE HIS GLN SEQRES 11 A 287 HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA ASN PHE SEQRES 12 A 287 LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP PHE GLY SEQRES 13 A 287 ILE ALA ASN GLN MET GLN PRO ASP THR THR SER VAL VAL SEQRES 14 A 287 LYS ASP SER GLN VAL GLY TPO VAL ASN TYR MET PRO PRO SEQRES 15 A 287 GLU ALA ILE LYS ASP MET SER SER SER ARG GLU ASN GLY SEQRES 16 A 287 LYS SER LYS SER LYS ILE SER PRO LYS SER ASP VAL TRP SEQRES 17 A 287 SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR GLY LYS SEQRES 18 A 287 THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER LYS LEU SEQRES 19 A 287 HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU PHE PRO SEQRES 20 A 287 ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU LYS CYS SEQRES 21 A 287 CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER ILE PRO SEQRES 22 A 287 GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN THR HIS SEQRES 23 A 287 PRO MODRES 5NTT TPO A 686 THR MODIFIED RESIDUE HET TPO A 686 11 HET SVE A 801 49 HET EDO A 802 4 HET EDO A 803 4 HETNAM TPO PHOSPHOTHREONINE HETNAM SVE N-(2,6-DIETHYLPHENYL)-1-METHYL-8-({4-[(1- HETNAM 2 SVE METHYLPIPERIDIN-4-YL)CARBAMOYL]-2-(TRIFLUOROMETHOXY) HETNAM 3 SVE PHENYL}AMINO)-4,5-DIHYDRO-1H-PYRAZOLO[4,3- HETNAM 4 SVE H]QUINAZOLINE-3-CARBOXAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 SVE C35 H39 F3 N8 O3 FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 HOH *32(H2 O) HELIX 1 AA1 ASP A 561 GLN A 579 1 19 HELIX 2 AA2 LEU A 609 LYS A 615 1 7 HELIX 3 AA3 ASP A 620 GLN A 640 1 21 HELIX 4 AA4 LYS A 649 ALA A 651 5 3 HELIX 5 AA5 PRO A 691 MET A 698 1 8 HELIX 6 AA6 PRO A 713 GLY A 730 1 18 HELIX 7 AA7 ASN A 739 ASP A 749 1 11 HELIX 8 AA8 GLU A 761 LEU A 772 1 12 HELIX 9 AA9 SER A 781 ALA A 787 1 7 HELIX 10 AB1 HIS A 788 ILE A 793 1 6 SHEET 1 AA1 6 SER A 517 VAL A 520 0 SHEET 2 AA1 6 ARG A 523 SER A 533 -1 O TYR A 525 N MET A 518 SHEET 3 AA1 6 SER A 537 LEU A 543 -1 O GLN A 541 N LYS A 529 SHEET 4 AA1 6 ILE A 549 ASN A 556 -1 O TYR A 554 N LYS A 538 SHEET 5 AA1 6 TYR A 597 MET A 602 -1 O MET A 602 N ALA A 551 SHEET 6 AA1 6 LEU A 588 ILE A 593 -1 N ASP A 590 O VAL A 601 SHEET 1 AA2 3 ILE A 607 ASP A 608 0 SHEET 2 AA2 3 PHE A 653 VAL A 656 -1 O ILE A 655 N ILE A 607 SHEET 3 AA2 3 MET A 659 LEU A 662 -1 O LYS A 661 N LEU A 654 LINK C GLY A 685 N TPO A 686 1555 1555 1.34 LINK C TPO A 686 N VAL A 687 1555 1555 1.34 SITE 1 AC1 18 TYR A 514 LYS A 529 ILE A 531 SER A 533 SITE 2 AC1 18 GLY A 534 SER A 537 GLN A 541 ALA A 551 SITE 3 AC1 18 LYS A 553 MET A 602 GLU A 603 TYR A 604 SITE 4 AC1 18 GLY A 605 ASN A 606 ASP A 608 SER A 611 SITE 5 AC1 18 LEU A 654 ILE A 663 SITE 1 AC2 4 TRP A 622 LYS A 625 SER A 626 LYS A 629 SITE 1 AC3 4 SER A 526 LYS A 547 TYR A 604 ASP A 657 CRYST1 70.672 112.010 116.126 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014150 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008928 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008611 0.00000